Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,454.80 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
Nasdaq 2,837.53 -1.85 -0.07%
Ticker Volume Price Price Delta
STOXX 50 2,161.87 +5.35 0.25%
FTSE 100 5,351.53 +1.48 0.03%
DAX 6,339.94 +24.05 0.38%
Ticker Volume Price Price Delta
Nikkei 8,580.39 +17.01 0.20%
TOPIX 722.11 -0.14 -0.02%
Hang Seng 18,713.40 +47.01 0.25%
Gold 1,578.30 +0.45%
EUR-USD 1.2569 0.1076%
Nasdaq 2,837.53 -0.07%
DJIA 12,454.80 -0.60%
S&P 500 1,317.82 -0.22%
FTSE 100 5,351.53 +0.03%
STOXX 50 2,161.87 +0.25%
DAX 6,339.94 +0.38%
Oil (WTI) 91.32 +0.51%
U.S. 10-year 1.738% -0.039
BAC:US 7.15 +0.14%
FB:US 31.91 -3.39%
  • Exchange: London
  • Sector: Consumer, Non-cyclical
  • Industry: Healthcare-Products
  • Sub-Industry: Medical Products

Smith & Nephew PLC

Add to Portfolio

SN/:LN

605.5000 GBp 5.5000 0.92%

As of 11:35:08 ET on 05/25/2012.

Snapshot for Smith & Nephew PLC (SN/)

Open: 600.0000 Day's Range: 600.0000 - 610.5000 Volume: 3,114,218 Bid: 605.5000
Previous Close: 600.0000 52wk Range: 501.0000 - 700.0000 1-Yr Rtn: -8.93% Ask: 606.0000

Stock Chart for SN/

No chart data available.
  • SN/:LN 605.5000
  • 1D
  • 1M
  • 1Y
600.0000
Interactive SN/ Chart

Previous Close

Key Statistics for SN/

Current P/E Ratio (ttm) 14.4237
Estimated P/E (12/2012) 12.2708
Earnings Per Share (USD) (ttm) 0.6583
Est. EPS (USD) (12/2012) 0.7720
Est. PEG Ratio 1.7435
Market Cap (M GBP) 5,427.48
Shares Outstanding (M) 896.36
Enterprise Value (M USD) (ttm) 8,540.11
Enterprise Value/EBITDA (ttm) 6.97
Price/Book (mrq) 2.4636
Price/Sale (ttm) 1.9711
Dividend Indicated Gross Yield 2.0055
Next Earnings Announcement 08/02/2012
More SN/ Key Statistics mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Financials for SN/

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)
More SN/ Income Statement Data
  • Total Assets
  • Total Liabilities (M/USD)
  • Debt to Assets (%)
More SN/ Balance Sheet Data
  • Operating
  • Investing
  • Financing (M/USD)
More SN/ Cash Flow Data

Company Profile & Key Executives for SN/

Smith & Nephew plc develops and markets advanced medical devices. The Group is involved in orthopaedics, endoscopy, and advanced wound management.

John Gordon St Clair BuchananChairmanOlivier BohuonChief Executive Officer
Adrian HennahChief Financial OfficerRos RivazChief Technology Officer
More Company Profile & Key Executives for SN/

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Advertisements